Competitor Analysis: Thrombolytics & Fibrinolytics

Publisher: La Merie Publishing
Pages: 38
Format: PDF
Product Line:
Competitor Analysis
Product Code: LMCA0079
Release Date: May of 2013

250.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Thrombolytics & Fibrinolytics

Product description

The Competitive Intelligence Report Thrombolytics & Fibrinolytics as of May 2013 provides a competitor analysis in the product portfolios and development pipelines of novel thrombolytics and fibrinolytics for treatment of cardiovascular thrombosis, stroke and eye diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides information on the various generation of marketed thrombolytics and includes a compilation of current active projects in research and development of novel thrombolytics and fibrinolytics including those in development in ophthalmology and in less regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of thrombolytics and fibrinolytics. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. 

Competitor Analysis: Thrombolytics & Fibrinolytics

Table of Contents

  • Non-fibrin selective (1st generation) Fibrinolytics
  • Fibrin selective wild-type t-PA-based Fibrinolytics
  • Fibrin selective engineered t-PA-based Fibrinolytics
  • Non-t-PA-based Fibrinolytics
  • Plasmin-based Fibrinolytics
  • Adjunctive therapy to Fibrinolytics
  • Biosimilar Thrombolytics and Fibrinolytics in Non-Regulated Markets
  • Corporate Thrombolytic Product Portfolios and R&D Pipelines

The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up